| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |